The ONALABS company has been selected by the CIMTI acceleration platform to focus and strengthen the strategic line of non-invasive devices.

CIMTI has valued the idea and the technological impact of the ONALABS value proposition, and the feasibility of the innovative solution of monitoring cardiorespiratory chronicles remotely.